Radiation therapy firm North American Scientific (NAS) reported that its Nomos radiation oncology division has received regulatory approval from the People's Republic of China State Food and Drug Administration (SFDA) to sell its Peacock product, a serial tomotherapy system designed for cancer treatment with intensity-modulated radiation therapy (IMRT).
The Chatsworth, CA-based firm said it has established relationships with distributors, and that it maintains service personnel in China who are prepared to market, sell, and service the device. NAS said it believes that sales in China could occur before the end of its current fiscal year on October 31.
By AuntMinnie.com staff writers
September 21, 2005
Related Reading
NAS trims losses in Q3, September 6, 2005
NAS, Oncura sign palladium-103 deal, July 21, 2005
Nomos acquisition boosts NAS revenues, June 8, 2005
NAS files quarterly 10-Q report, April 18, 2005
Copyright © 2005 AuntMinnie.com
